Search research articles
Contact Us
Filters
Showing results (51-60 of 66) with videos related to
Page
of 7
Sort By:
Medical Care
|
November 5, 2021
A Comparison of Home Health Utilization, Outcomes, and Cost Between Medicare Advantage and Traditional Medicare
Adrianne W Casebeer, David Ronning, Richard Schwartz, et al.
Breast Cancer Research : BCR
|
December 15, 2021
Quantitative assessment of the immune microenvironment in African American Triple Negative Breast Cancer: a case-control study
Vesal Yaghoobi, Myrto Moutafi, Thazin Nwe Aung, et al.
NPJ Precision Oncology
|
July 9, 2026
Prognostic impact of somatic mutations among patients with pleural and peritoneal mesothelioma
Justin M Bader, Ankit Dhiman, Nicole Aguirre, et al.
The American Journal of Managed Care
|
April 20, 2021
Post-SNF outcomes and cost comparison: Medicare Advantage vs traditional Medicare
Adrianne W Casebeer, Richard Schwartz, Harmit Patel, et al.
Pancreas
|
December 3, 2021
Methylation-based Cell-free DNA Signature for Early Detection of Pancreatic Cancer
Lee Ying, Anup Sharma, Ankit Chhoda, et al.
The American Journal of Psychiatry
|
February 1, 2017
Common Dimensional Reward Deficits Across Mood and Psychotic Disorders: A Connectome-Wide Association Study
Anup Sharma, Daniel H Wolf, Rastko Ciric, et al.
Clinical Epigenetics
|
December 3, 2022
A randomized, phase II trial of oral azacitidine (CC-486) in patients with resected pancreatic adenocarcinoma at high risk for recurrence
Thatcher R Heumann, Marina Baretti, Elizabeth A Sugar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 12, 2018
A Phase I Trial of a Guadecitabine (SGI-110) and Irinotecan in Metastatic Colorectal Cancer Patients Previously Exposed to Irinotecan
Valerie Lee, Judy Wang, Marianna Zahurak, et al.
Cancer Medicine
|
July 4, 2014
Combining the pan-aurora kinase inhibitor AMG 900 with histone deacetylase inhibitors enhances antitumor activity in prostate cancer
Channing J Paller, Michel D Wissing, Janet Mendonca, et al.
Clinical Epigenetics
|
February 21, 2023
Utility of promoter hypermethylation in malignant risk stratification of intraductal papillary mucinous neoplasms
Ankit Chhoda, Anup Sharma, Bethsebie Sailo, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 66) with videos related to
Sort By:
Page
of 7
Medical Care
|
November 5, 2021
A Comparison of Home Health Utilization, Outcomes, and Cost Between Medicare Advantage and Traditional Medicare
Adrianne W Casebeer, David Ronning, Richard Schwartz, et al.
Breast Cancer Research : BCR
|
December 15, 2021
Quantitative assessment of the immune microenvironment in African American Triple Negative Breast Cancer: a case-control study
Vesal Yaghoobi, Myrto Moutafi, Thazin Nwe Aung, et al.
NPJ Precision Oncology
|
July 9, 2026
Prognostic impact of somatic mutations among patients with pleural and peritoneal mesothelioma
Justin M Bader, Ankit Dhiman, Nicole Aguirre, et al.
The American Journal of Managed Care
|
April 20, 2021
Post-SNF outcomes and cost comparison: Medicare Advantage vs traditional Medicare
Adrianne W Casebeer, Richard Schwartz, Harmit Patel, et al.
Pancreas
|
December 3, 2021
Methylation-based Cell-free DNA Signature for Early Detection of Pancreatic Cancer
Lee Ying, Anup Sharma, Ankit Chhoda, et al.
The American Journal of Psychiatry
|
February 1, 2017
Common Dimensional Reward Deficits Across Mood and Psychotic Disorders: A Connectome-Wide Association Study
Anup Sharma, Daniel H Wolf, Rastko Ciric, et al.
Clinical Epigenetics
|
December 3, 2022
A randomized, phase II trial of oral azacitidine (CC-486) in patients with resected pancreatic adenocarcinoma at high risk for recurrence
Thatcher R Heumann, Marina Baretti, Elizabeth A Sugar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 12, 2018
A Phase I Trial of a Guadecitabine (SGI-110) and Irinotecan in Metastatic Colorectal Cancer Patients Previously Exposed to Irinotecan
Valerie Lee, Judy Wang, Marianna Zahurak, et al.
Cancer Medicine
|
July 4, 2014
Combining the pan-aurora kinase inhibitor AMG 900 with histone deacetylase inhibitors enhances antitumor activity in prostate cancer
Channing J Paller, Michel D Wissing, Janet Mendonca, et al.
Clinical Epigenetics
|
February 21, 2023
Utility of promoter hypermethylation in malignant risk stratification of intraductal papillary mucinous neoplasms
Ankit Chhoda, Anup Sharma, Bethsebie Sailo, et al.
Page
of 7